183 related articles for article (PubMed ID: 31949182)
1. Blockade of Arginine Vasopressin receptors prevents blood-brain barrier breakdown in Experimental Autoimmune Encephalomyelitis.
Viñuela-Berni V; Gómez-González B; Quintanar-Stephano A
Sci Rep; 2020 Jan; 10(1):467. PubMed ID: 31949182
[TBL] [Abstract][Full Text] [Related]
2. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
Zeynalov E; Jones SM; Seo JW; Snell LD; Elliott JP
PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
[TBL] [Abstract][Full Text] [Related]
3. Effects of neurointermediate pituitary lobectomy and desmopressin on acute experimental autoimmune encephalomyelitis in Lewis rats.
Quintanar-Stephano A; Organista-Esparza A; Chavira-Ramírez R; Kovacs K; Berczi I
Neuroimmunomodulation; 2012; 19(3):148-57. PubMed ID: 22262014
[TBL] [Abstract][Full Text] [Related]
4. Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats.
Quintanar-Stephano A; Chavira-Ramírez R; Kovacs K; Berczi I
J Endocrinol; 2005 Jan; 184(1):51-8. PubMed ID: 15642782
[TBL] [Abstract][Full Text] [Related]
5. Arginine vasopressin deficiency and conivaptan (a V1a-V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis.
Navarro-Gonzalez YD; Ventura-Juarez J; Muñoz-Ortega MH; González-Blas D; Calvillo-Robedo A; Avila-Blanco ME; Valdez-Urias F; Quintanar-Stephano A
Int J Exp Pathol; 2023 Aug; 104(4):209-222. PubMed ID: 36964979
[TBL] [Abstract][Full Text] [Related]
6. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis.
Rousseau V; Denizot B; Le Jeune JJ; Jallet P
Exp Brain Res; 1999 Apr; 125(3):255-64. PubMed ID: 10229016
[TBL] [Abstract][Full Text] [Related]
7. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
Pfeiffer F; Schäfer J; Lyck R; Makrides V; Brunner S; Schaeren-Wiemers N; Deutsch U; Engelhardt B
Acta Neuropathol; 2011 Nov; 122(5):601-14. PubMed ID: 21983942
[TBL] [Abstract][Full Text] [Related]
8. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation.
Dimitriadou V; Pang X; Theoharides TC
Int J Immunopharmacol; 2000 Sep; 22(9):673-84. PubMed ID: 10884588
[TBL] [Abstract][Full Text] [Related]
10. Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries.
Grygorowicz T; Dąbrowska-Bouta B; Strużyńska L
Purinergic Signal; 2018 Dec; 14(4):385-393. PubMed ID: 30091000
[TBL] [Abstract][Full Text] [Related]
11. Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment.
Calvillo-Robledo A; Ramírez-Farías C; Valdez-Urias F; Huerta-Carreón EP; Quintanar-Stephano A
Front Neurosci; 2023; 17():1138627. PubMed ID: 36998727
[TBL] [Abstract][Full Text] [Related]
12. 2-(2-Benzofuranyl)-2-Imidazoline Attenuates the Disruption of the Blood-Brain Barrier in EAE via NMDAR.
Xia N; Hua Y; Li J; Chen Y; Li X; Lin J; Xu H; Xie C; Wang X
Neurochem Res; 2021 Jul; 46(7):1674-1685. PubMed ID: 33772673
[TBL] [Abstract][Full Text] [Related]
13. [Vasopressin and blood-brain barrier].
Nagao S
No To Shinkei; 1998 Sep; 50(9):809-15. PubMed ID: 9789303
[TBL] [Abstract][Full Text] [Related]
14. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
15. ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.
Zheng M; Wei J; Tang Y; Yang C; Wei Y; Yin X; Liu Q
J Mol Neurosci; 2014; 54(2):282-90. PubMed ID: 24788224
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic response to experimental allergic encephalomyelitis: role of substance P.
Ruocco HH; Fernandes GA; Namer IJ; Depaulis A; Levy S
Neuroimmunomodulation; 2004; 11(1):28-35. PubMed ID: 14557676
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
18. The role of arginine vasopressin and its receptors in the normal and failing rat heart.
Chandrashekhar Y; Prahash AJ; Sen S; Gupta S; Roy S; Anand IS
J Mol Cell Cardiol; 2003 May; 35(5):495-504. PubMed ID: 12738231
[TBL] [Abstract][Full Text] [Related]
19. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease.
Koh CS; Gausas J; Paterson PY
J Neuroimmunol; 1993 Sep; 47(2):141-5. PubMed ID: 8370766
[TBL] [Abstract][Full Text] [Related]
20. Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1a receptor.
Pascale CL; Szmydynger-Chodobska J; Sarri JE; Chodobski A
J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():161-7. PubMed ID: 17244947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
